Champions Oncology (NASDAQ:CSBR) Posts Earnings Results, Beats Estimates By $0.06 EPS
Champions Oncology (NASDAQ:CSBR – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.06, FiscalAI reports. The company had revenue of $15.23 million during the quarter, compared to the consensus estimate of $15.04 million. Champions […]
10 Sep 20:10 · The Markets Daily